Lee R. Machado

University of Northampton — United Kingdom

Immunology and Microbiology · Life Sciences

25h-index2.4kcitations125works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immune Cell Function and Interaction(16), Monoclonal and Polyclonal Antibodies Research(14), Parasitic infections in humans and animals(14), Immunotherapy and Immune Responses(13), Viral-associated cancers and disorders(13)

Publications125 total

8 Duchenne muscular dystrophy gene product expression is associated with increased survival in head and neck squamous cell carcinoma
British Journal of Oral and Maxillofacial Surgery·2025
A unified model for Duchenne muscular dystrophy gene involvement in cancer: context‐dependent tumour suppression and oncogenicity
FEBS Open Bio·2025Open Access
Dietary Phytoestrogen Increases Tumour Size and the Frequency of Circulating Tregs in a B16-F10 Murine Melanoma Tumour Model
Diyala Journal of Medicine·2025Open Access
Duchenne muscular dystrophy gene product expression is associated with survival in head and neck squamous cell carcinoma
Scientific Reports·2025· 2 citedOpen Access
34P Association between Duchenne muscular dystrophy gene products and prognosis in head and neck cancer
ESMO Open·2025Open Access
89P Duchenne muscular dystrophy gene product expression is associated with survival in sarcoma
ESMO Open·2025· 1 citedOpen Access
Epigenetics of concussion: A systematic review
Gene·2024· 3 citedOpen Access
Developing a Multidimensional Fuzzy Deep Learning for Cancer Classification using Gene Expression Data
2023· 2 citedOpen Access
Table of Contents
2023Open Access
Enhancing Cancer Classification Through the Development of a Fuzzy Gene Selection-Wrapper Plus Method
2023· 1 cited
Intersection Three Feature Selection and Machine Learning Approaches for Cancer Classification
2023· 4 cited
Fuzzy Gene Selection and Cancer Classification Based on Deep Learning Model
arXiv (Cornell University)·2023· 5 citedOpen Access
Data from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S1 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S2 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S3 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S3 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S2 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Data from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
Supplementary Figure S1 from Human Leukocyte Antigen (HLA) A*1101-Restricted Epstein-Barr Virus–Specific T-cell Receptor Gene Transfer to Target Nasopharyngeal Carcinoma
2023Open Access
page 1 of 7Next →

Frequent Co-authors

J. A. Livramento(20), A. Spina-França(13), Edward J. Hollox(9), J. P. S. Nóbrega(8), L.S. Vianna(6), Karen Anthony(4), Leandro Tavares Lucato(4), Jonathan C. Strefford(3), Luiz Alberto Bacheschi(3), Daniel Ciampi de Andrade(3), Ronaldo Abraham(3), Luiz Henrique Martins Castro(3), Robert J. Hardwick(3), Luciana W. Zuccherato(3), Eduardo Tarazona‐Santos(3), Steven P. Lee(3), Karen Piper Hanley(2), Chantal E. Hargreaves(2), Matthew Rose‐Zerilli(2), Chisako Iriyama(2)